Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Juni 2019

Planlagt Fastgjort Låst Flyttet Genmab
2.2k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • V Offline
    V Offline
    Vitus
    wrote on sidst redigeret af
    #1800

    Hvem andre herinde må ikke kritiseres ??

    1 Reply Last reply
    0
    • G Offline
      G Offline
      GeorgeBest
      wrote on sidst redigeret af
      #1801

      Her

      1 Reply Last reply
      0
      • G Offline
        G Offline
        GeorgeBest
        wrote on sidst redigeret af
        #1802

        Alle må kritiseres pænt og ordentligt

        1 Reply Last reply
        0
        • M Offline
          M Offline
          mobbyduck1
          wrote on sidst redigeret af
          #1803

          @Vitus, Georgebest har altså ret, der findes ikke bedre end Bulder og Sukkeralf, super dygtige og saglige

          1 Reply Last reply
          0
          • JørgenVarnæsJ Offline
            JørgenVarnæsJ Offline
            JørgenVarnæs
            wrote on sidst redigeret af
            #1804

            Hvis kommentarerne kunne holdes til at omhandle emnet og ikke skribenten, så ville vi være langt. Men nogle drømme må jo dø.

            1 Reply Last reply
            0
            • V Offline
              V Offline
              Vitus
              wrote on sidst redigeret af
              #1805

              Du er da også altid så formildende Pensionisten....det kan nu engang ikke være rigtig at fordi man har taget fejl, er der da ingen grund til at komme med et utal af undskyldninger ....så må funderingen da forbedres....

              1 Reply Last reply
              0
              • G Offline
                G Offline
                gentogen
                wrote on sidst redigeret af
                #1806

                Det tog 5 måneder for Pembrolizumab. Side 13. https://www.focr.org/sites/default/files/Friends Annual Meeting Panel 3 Slides.pdf

                1 Reply Last reply
                0
                • JørgenVarnæsJ Offline
                  JørgenVarnæsJ Offline
                  JørgenVarnæs
                  wrote on sidst redigeret af
                  #1807

                  jeg tænker, at der ingen grund er til panik. Fda ved jo også, at de har fremtidens SOC mellem hænderne. Så skal t’erne krydses og i’erne dottes til perfektion

                  1 Reply Last reply
                  0
                  • troldmandenT Offline
                    troldmandenT Offline
                    troldmanden
                    wrote on sidst redigeret af
                    #1808

                    Lad os da håbe der ikke går 5 mdr for maia. For så lugter begynder det af nedjustering

                    1 Reply Last reply
                    0
                    • V Offline
                      V Offline
                      Vitus
                      wrote on sidst redigeret af
                      #1809

                      Ja, og så får kursen yderligere et hug....der er jo langt bare til 1480...

                      1 Reply Last reply
                      0
                      • K Offline
                        K Offline
                        KWC
                        wrote on sidst redigeret af
                        #1810

                        Yes!

                        1 Reply Last reply
                        0
                        • H Offline
                          H Offline
                          Hen
                          wrote on sidst redigeret af
                          #1811

                          https://mail.google.com/mail/u/0/#inbox/WhctKJVRNJsrRLLPSFrSDBZjjHDxzhrjQgFhHvJpPjpRRWfhtLgThWJmSwWtcVMQJkWsDDB

                          1 Reply Last reply
                          0
                          • SolsenS Offline
                            SolsenS Offline
                            Solsen
                            wrote on sidst redigeret af
                            #1812

                            Du har slet ikke nerver til biotech Vitus

                            1 Reply Last reply
                            0
                            • K Offline
                              K Offline
                              KWC
                              wrote on sidst redigeret af
                              #1813

                              Genmab Announces U.S. FDA Approval of DARZALEX® (daratumumab) in Combination with Lenalidomide and Dexamethasone in Frontline Multiple Myeloma
                              Company Announcement

                              DARZALEX (daratumumab) approved by U.S. FDA in combination with lenalidomide and dexamethasone for the treatment of adult patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplant
                              Approval based on Phase III MAIA study
                              Copenhagen, Denmark; June 27, 2019 – Genmab A/S (Nasdaq Copenhagen: GEN)

                              1 Reply Last reply
                              0
                              • SolsenS Offline
                                SolsenS Offline
                                Solsen
                                wrote on sidst redigeret af
                                #1814

                                Haha

                                1 Reply Last reply
                                0
                                • K Offline
                                  K Offline
                                  KWC
                                  wrote on sidst redigeret af
                                  #1815

                                  offer their patients the option to add DARZALEX to this regimen in the U.S.,” said Jan van de Winkel, Ph.D., Chief Executive Officer of Genmab.

                                  The approval was based on data from the Phase III MAIA (MMY3008) study of daratumumab in combination with lenalidomide and dexamethasone as treatment for patients with newly diagnosed multiple myeloma, who are not candidates for high dose chemotherapy and ASCT. Data from this study was presented as a Late-Breaking Abstract at the 2018 American Society o

                                  1 Reply Last reply
                                  0
                                  • JørgenVarnæsJ Offline
                                    JørgenVarnæsJ Offline
                                    JørgenVarnæs
                                    wrote on sidst redigeret af
                                    #1816

                                    Dejligt!

                                    1 Reply Last reply
                                    0
                                    • V Offline
                                      V Offline
                                      Vitus
                                      wrote on sidst redigeret af
                                      #1817

                                      Hvad mener du ? ....jeg rører aldrig mine Genmab aktier. Jeg kommenterer bare på fakta !

                                      1 Reply Last reply
                                      0
                                      • SolsenS Offline
                                        SolsenS Offline
                                        Solsen
                                        wrote on sidst redigeret af
                                        #1818

                                        Så have Andrew ret i at det blev H1 😉

                                        1 Reply Last reply
                                        0
                                        • troldmandenT Offline
                                          troldmandenT Offline
                                          troldmanden
                                          wrote on sidst redigeret af
                                          #1819

                                          Fedt!

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger